Parental willingness to have children vaccinated against COVID-19 in Geneva, Switzerland: a cross-sectional population-based study

Author:

Baysson Hélène,Pullen Nick,De Mestral Carlos,Semaani Claire,Pennacchio Francesco,Zaballa María-Eugenia,L’Huillier Arnaud G.,Lorthe Elsa,Guessous Idris,Stringhini Silvia,The Specchio-COVID19 study group

Abstract

OBJECTIVE: We aimed to examine factors associated with parental willingness to vaccinate their children against COVID-19. METHODS: We surveyed adults included in a digital longitudinal cohort study composed of participants in previous SARS-CoV-2 serosurveys conducted in Geneva, Switzerland. In February 2022, an online questionnaire collected information on COVID-19 vaccination acceptance, parental willingness to vaccinate their children aged ≥5 years and reasons for vaccination preference. We used multivariable logistic regression to assess the demographic, socioeconomic and health-related factors associated with being vaccinated and with parental intention to vaccinate their children. RESULTS: We included 1,383 participants (56.8% women; 69.3% aged 35–49 years). Parental willingness to vaccinate their children increased markedly with the child’s age: 84.0%, 60.9% and 21.2%, respectively, for parents of adolescents aged 16–17 years, 12–15 years and 5–12 years. For all child age groups, unvaccinated parents more frequently indicated not intending to vaccinate their children than vaccinated parents. Refusal to vaccine children was associated with having a secondary education (1.73; 1.18–2.47) relative to a tertiary education and with middle (1.75; 1.18–2.60) and low (1.96; 1.20–3.22) household income relative to high income. Refusal to vaccine their children was also associated with only having children aged 12–15 years (3.08; 1.61–5.91), aged 5–11 years (19.77; 10.27–38.05), or in multiple age groups (6.05; 3.22–11.37), relative to only having children aged 16–17 years. CONCLUSION: Willingness to vaccinate children was high for parents of adolescents aged 16–17 years but decreased significantly with decreasing child age. Unvaccinated, socioeconomically disadvantaged parents and those with younger children were less likely to be willing to vaccinate their children. These results are important for vaccination programs and developing communication strategies to reach vaccine-hesitant groups, both in the context of COVID-19 and in the prevention of other diseases and future pandemics.

Publisher

SMW Supporting Association

Subject

General Medicine

Reference41 articles.

1. Klein NP, Stockwell MS, Demarco M, Gaglani M, Kharbanda AB, Irving SA, et al. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar;71(9):352–8. https://doi.org/10.15585/mmwr.mm7109e3 PMID:35239634

2. Dorabawila V, Hoefer D, Bauer UE, Bassett MT, Lutterloh E, Rosenberg ES. Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant. medRxiv. Published online January 1, 2022:2022.02.25.22271454. https://doi.org/10.1101/2022.02.25.22271454.

3. Walter EB, Talaat KR, Sabharwal C, Gurtman A, Lockhart S, Paulsen GC, et al.; C4591007 Clinical Trial Group. Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. N Engl J Med. 2022 Jan;386(1):35–46. https://doi.org/10.1056/NEJMoa2116298 PMID:34752019

4. Nordström P, Ballin M, Nordström A. Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden. Lancet. 2022 Feb;399(10327):814–23. https://doi.org/10.1016/S0140-6736(22)00089-7 PMID:35131043

5. General Health Directorate of Canton of Geneva. Vaccination in Geneva: numbers and campaign. ge.ch. Accessed July 1, 2022. https://www.ge.ch/en/node/23804

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3